BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 37298365)

  • 1. Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances.
    Golub A; Ordak M; Nasierowski T; Bujalska-Zadrozny M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers of isoniazid-induced liver injury: Aminotransferases are insufficient, and OPN, L-FABP and HMGB1 can be promising novel biomarkers.
    Cheng X; Zhu JL; Li Y; Luo WW; Xiang HR; Zhang QZ; Peng WX
    J Appl Toxicol; 2022 Mar; 42(3):516-528. PubMed ID: 34494278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
    Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
    Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk prediction of hepatotoxicity in paracetamol poisoning.
    Wong A; Graudins A
    Clin Toxicol (Phila); 2017 Sep; 55(8):879-892. PubMed ID: 28447858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C in a psychiatric setting: A forgotten reservoir?].
    Rolland B; Bailly F; Cutarella C; Drevon O; Carrieri P; Darque A; Hallouche N; Maptue N; Pol S; Llorca PM; Lang JP
    Encephale; 2021 Apr; 47(2):181-184. PubMed ID: 32473777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study.
    Douros A; Bronder E; Andersohn F; Klimpel A; Thomae M; Sarganas G; Kreutz R; Garbe E
    Br J Clin Pharmacol; 2015 Jun; 79(6):988-99. PubMed ID: 25444550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.
    Tetrault JM; Tate JP; Edelman EJ; Gordon AJ; Lo Re V; Lim JK; Rimland D; Goulet J; Crystal S; Gaither JR; Gibert CL; Rodriguez-Barradas MC; Fiellin LE; Bryant K; Justice AC; Fiellin DA
    J Subst Abuse Treat; 2016 Sep; 68():62-7. PubMed ID: 27431048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
    Arriazu E; Ge X; Leung TM; Magdaleno F; Lopategi A; Lu Y; Kitamura N; Urtasun R; Theise N; Antoine DJ; Nieto N
    Gut; 2017 Jun; 66(6):1123-1137. PubMed ID: 26818617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort.
    Church RJ; Kullak-Ublick GA; Aubrecht J; Bonkovsky HL; Chalasani N; Fontana RJ; Goepfert JC; Hackman F; King NMP; Kirby S; Kirby P; Marcinak J; Ormarsdottir S; Schomaker SJ; Schuppe-Koistinen I; Wolenski F; Arber N; Merz M; Sauer JM; Andrade RJ; van Bömmel F; Poynard T; Watkins PB
    Hepatology; 2019 Feb; 69(2):760-773. PubMed ID: 29357190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort.
    Torti C; Lapadula G; Puoti M; Casari S; Uccelli MC; Cristini G; Bella D; Pastore G; Ladisa N; Minoli L; Sotgiu G; Caputo SL; Bonora S; Carosi G
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):180-5. PubMed ID: 16394850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix and Sampling Effects on Quantification of Protein Biomarkers of Drug-Induced Liver Injury.
    Anselm V; Sommersdorf C; Carrasco-Triguero M; Katavolos P; Planatscher H; Steinhilber A; Joos T; Poetz O
    J Proteome Res; 2021 Nov; 20(11):4985-4994. PubMed ID: 34554759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends.
    Danjuma MI; Sajid J; Fatima H; Elzouki AN
    Medicine (Baltimore); 2019 Dec; 98(50):e18322. PubMed ID: 31852121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.
    Antoine DJ; Dear JW; Lewis PS; Platt V; Coyle J; Masson M; Thanacoody RH; Gray AJ; Webb DJ; Moggs JG; Bateman DN; Goldring CE; Park BK
    Hepatology; 2013 Aug; 58(2):777-87. PubMed ID: 23390034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatotoxicity and virological breakthrough of HCV following treatment with sofosbuvir, daclatasvir, and ribavirin in patients previously treated for tuberculosis.
    Wahid B
    J Med Virol; 2019 Dec; 91(12):2195-2197. PubMed ID: 31347729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.
    Torti C; Costarelli S; De Silvestri A; Quiros-Roldan E; Lapadula G; Cologni G; Paraninfo G; Castelnuovo F; Puoti M; Carosi G;
    Drug Saf; 2007; 30(12):1161-9. PubMed ID: 18035868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic modulation of acetaminophen-induced hepatotoxicity by osteopontin.
    Wen Y; Wang C; Gu J; Yu C; Wang K; Sun X; Sun Y; Wu H; Tong Y; Xia Q; Kong X
    Cell Mol Immunol; 2019 May; 16(5):483-494. PubMed ID: 29735980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAMPs and sterile inflammation in drug hepatotoxicity.
    Yang R; Tonnesseen TI
    Hepatol Int; 2019 Jan; 13(1):42-50. PubMed ID: 30474802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral and anti-hepatitis C virus direct-acting antiviral-related hepatotoxicity.
    Han H; Agarwal R; Martel-Laferriere V; Dieterich DT
    Clin Liver Dis; 2013 Nov; 17(4):657-70, ix. PubMed ID: 24099023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
    Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
    BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.